Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Gain-of-Function Mutations of c- <i>kit</i> in Human Gastrointestinal Stromal Tumors
4.459
Zitationen
15
Autoren
1998
Jahr
Abstract
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors in the human digestive tract, but their molecular etiology and cellular origin are unknown. Sequencing of c-kit complementary DNA, which encodes a proto-oncogenic receptor tyrosine kinase (KIT), from five GISTs revealed mutations in the region between the transmembrane and tyrosine kinase domains. All of the corresponding mutant KIT proteins were constitutively activated without the KIT ligand, stem cell factor (SCF). Stable transfection of the mutant c-kit complementary DNAs induced malignant transformation of Ba/F3 murine lymphoid cells, suggesting that the mutations contribute to tumor development. GISTs may originate from the interstitial cells of Cajal (ICCs) because the development of ICCs is dependent on the SCF-KIT interaction and because, like GISTs, these cells express both KIT and CD34.
Ähnliche Arbeiten
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 · 7.177 Zit.
Comprehensive molecular characterization of gastric adenocarcinoma
2014 · 6.368 Zit.
WHO Classification of Tumours of the Digestive System
2010 · 4.816 Zit.
Gastric cancer
2020 · 4.614 Zit.
Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors
2002 · 4.370 Zit.